• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • Transparency and accountability

    How Big Pharma kept COVID-19 vaccine negotiations in South Africa secret

    Newly released confidential contracts and documents show how drugmakers sought to prevent South African officials from even revealing that negotiations were underway and undercut suggestions to make the process more transparent.

    By Andrew Green // 23 May 2024

    At the height of the COVID-19 pandemic, multinational drug companies sought to dictate the terms on which the South African government could negotiate for access to COVID-19 vaccines, according to newly released confidential contracts and documents.

    That includes revelations that Moderna would not even allow the government to reveal that discussions were underway and Pfizer’s apparent rejection of any effort by South African officials to hold the drugmaker accountable for the late or incomplete delivery of doses or to include flexibilities allowing the government to be more transparent about the agreements the two sides ultimately reached.

    “The concessions these companies demanded undermined our democracy,” Fatima Hassan, the founder and director of the Health Justice Initiative, said on a conference call this week. She said the secrecy surrounding the negotiations and the agreements prevented parliament or any government watchdogs from playing an oversight role.

    This article is free to read - just register or sign in

    Access news, newsletters, events and more.

    Join usSign in

    Read more:

    ► Big Pharma 'bullying' exposed in South African COVID-19 contracts

    ► Africa CDC calls out Moderna for 'abandoning' vaccine equity commitment

    ► Big Pharma slammed for executive payouts that nearly match R&D budget

    • Global Health
    • Funding
    • Private Sector
    • Democracy, Human Rights & Governance
    • Public Citizen
    • Health Justice Initiative
    • South Africa
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Andrew Green

      Andrew Green@_andrew_green

      Andrew Green, a 2025 Alicia Patterson Fellow, works as a contributing reporter for Devex from Berlin.

    Search for articles

    Most Read

    • 1
      Opinion: How climate philanthropy can solve its innovation challenge
    • 2
      The legal case threatening to upend philanthropy's DEI efforts
    • 3
      Why most of the UK's aid budget rise cannot be spent on frontline aid
    • 4
      How is China's foreign aid changing?
    • 5
      2024 US foreign affairs funding bill a 'slow-motion gut punch'
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement